Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,

Slides:

Advertisements

Similar presentations

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Advertisements

The STS National Database

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Benny Weksler, MD, Jennifer L. Sullivan, MD

Thomas J. Birdas, MD, Richard P. M

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Joshua E. Rosen, BASc, Hari B

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis Dong Zhou, MD, Xu-Feng Deng, MD, Quan-Xing.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Amr Mohammad Allama, MD The Annals of Thoracic Surgery

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Factors Predicting Recurrence and Postrecurrence Survival in Completely Resected Thymic Carcinoma Yi-Ting Yen, MD, Wu-Wei Lai, MD, Kai-Wei Chang, MD,

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Samuel P. Morreau, David A. Haydock, MBChB, FRACS

Robotic Thymectomy in Anterior Mediastinal Mass: Propensity Score Matching Study With Transsternal Thymectomy Chang Hyun Kang, MD, PhD, Yoohwa Hwang,

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Who Do You Say You Are? The Annals of Thoracic Surgery

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Pulmonary Resection for Lung Cancer in Octogenarians

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Characteristics of Malignant Pleural Mesothelioma in Women

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Differentiating N0 Versus N1 Lung Cancer Kazuhiro Yasufuku, MD, PhD, Takahiro Nakajima,

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Editorial Board, January 2010

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

William M. Whited, MD, Paul Henley, BS, Erin M

Comparison of Neoadjuvant Chemotherapy Followed by Surgery to Upfront Surgery for Thymic Malignancy Samina Park, MD, In Kyu Park, MD, PhD, Young Tae.

David C. Rice, MB, BCh, Jeremy J. Erasmus, MD, Craig W

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Specialty Training and Mortality After Esophageal Cancer Resection

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide.

Prognostic Analysis for Survival After Resections of Localized Primary Cardiac Sarcomas: A Single-Institution Experience Hua Li, MD, PhD, Deming Xu,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Benny Weksler, MD, Manisha Shende, MD, Katie S

The Role of Video-Assisted Thoracoscopic Surgery in Therapeutic Lung Resection for Pulmonary Tuberculosis Yi-Ting Yen, MD, Ming-Ho Wu, MD, Wu-Wei Lai,

Survival Benefits of Postoperative Chemoradiation for Lymph Node–Positive Esophageal Squamous Cell Carcinoma Po-Kuei Hsu, MD, Chien-Sheng Huang, MD,

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Factors in the Selection and Management of Chest Tubes After Pulmonary Lobectomy: Results of a National Survey of Thoracic Surgeons Samuel S. Kim, MD,

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Presentation transcript:

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD, Zain Khalpey, MD, PhD, Baldasarre Stea, MD, PhD, Sun Yi, MD, Charles C. Hsu, MD, PhD The Annals of Thoracic Surgery Volume 107, Issue 1, Pages 194-201 (January 2019) DOI: 10.1016/j.athoracsur.2018.07.081 Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Flow diagram of patient selection and propensity matching. (NOS = not otherwise specified.) The Annals of Thoracic Surgery 2019 107, 194-201DOI: (10.1016/j.athoracsur.2018.07.081) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall survival of patients with sarcomatoid mesothelioma: (A) patients who did and did not undergo resection, and (B) patients who underwent resection versus those who received chemotherapy or radiotherapy (RT) or both, without resection. The Annals of Thoracic Surgery 2019 107, 194-201DOI: (10.1016/j.athoracsur.2018.07.081) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall survival of patients with biphasic mesothelioma: (A) patients who did and did not undergo resection, and (B) patients who underwent resection versus those who received chemotherapy or radiotherapy (RT) or both, without resection. The Annals of Thoracic Surgery 2019 107, 194-201DOI: (10.1016/j.athoracsur.2018.07.081) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions